Updates on MDMA-Assisted Psychotherapy for PTSD Studies: Research from Around the World
Channel: MAPS
Date: 2013-07-24

https://2013.psychedelicscience.org
https://www.maps.org

Updates on MDMA-Assisted Psychotherapy for PTSD Studies: Colorado, Israel, Canada, the UK, and Australia

Andrew Feldmár, Jim Grigsby, PhD, Marcela Ot'alora, LPC, Ben Sessa, MD, Keren Tzarfatyl, PhD (C), and Martin Williams, PhD

Abstract: In addition to completed and ongoing MAPS-sponsored studies in the US and Switzerland, this roundtable will consist of brief updates on Phase 2 studies of MDMA-assisted psychotherapy for PTSD underway or in the approval process in Boulder, Colorado; Israel; Canada; the UK; and Australia. Innovations in the various protocol designs will be highlighted as part of the overall effort to refine the scientific methodology for the Phase 3 protocol designs.

Andrew Feldmár is a psychotherapist in private practice in Vancouver, Canada. He has been studying the use of entheogens for somatic, psychological, and spiritual emergencies since 1967. He teaches, lectures, and publishes both in North America and in Europe (andrewfeldmar.ca).

Jim Grigsby, PhD, is a Professor in the Department of Medicine at the University of Colorado Denver School of Medicine, and in the Department of Psychology at UCD. A cognitive neuroscientist and health services researcher, he has over 200 scientific publications on various subjects. 

Marcela Ot'alora G. was born and raised in Colombia and now lives in Boulder, Colorado. She has a MA in Transpersonal Psychology and a MFA in Fine Arts. Marcela is an Installation artist and has an innovative private psychotherapy practice in Boulder. 

Dr. Ben Sessa, MD is a Child and Adolescent Psychiatrist from Bristol, UK. He has published commentary in the medical and popular press on psychedelic research in the UK for the last eight years in an attempt to bring this subject into mainstream British medicine. 

Keren Tzarfaty, M.A., Ph.D(c) in East-West Psychology from the California Institute of Integral Studies (CIIS), works with a wide range of people seeking healing and psychospiritual growth. In her work she addresses relationship challenges, anxiety, depression, PTSD, and works to help clients manifest their potential and live life fully. 

Martin Williams, PhD, is a Melbourne, Australia-based research fellow in structural biology and medicinal chemistry. He is a founding member of Entheogenesis Australis (EGA), a non-profit educational/harm-minimization association that fosters mature, open discussion about psychoactive plants and chemicals, seeking ways to assess their societal impacts and promote their benefits.

More videos available at https://2013.psychedelicscience.org

At Psychedelic Science 2013, over 100 of the world's leading researchers and more than 1,900 international attendees gathered to share recent findings on the benefits and risks of LSD, psilocybin, MDMA, ayahuasca, ibogaine, 2C-B, ketamine, DMT, marijuana, and more, over three days of conference presentations, and two days of pre- and post-conference workshops.